Ecl.Ax
ECL.AX operates in the investment management and fund operators industry, providing banking and investment services to its clients.
Business. Ecolab Inc (ECL.O) is a diversified specialty chemicals company headquartered in the United States and listed on the NASDAQ exchange. The firm operates within the Basic Materials sector, providing branded formulations and specialty chemical products. As specific operating segment and geographic breakdowns are not provided, the company is described at the industry level as a provider of diversified specialty chemicals.
Analyst recommendations
28 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressJohn Boozman — Ecolab Inc. Common Stock2026-05-15 · Republican · AR · Sale · $1,001 - $15,000
- CongressJohn Boozman — Ecolab Inc. Common Stock2026-05-15 · Republican · AR · Sale · $1,001 - $15,000
- CongressLisa McClain — Ecolab Inc. Common Stock2025-10-31 · Republican · MI · Sale · $1,001 - $15,000
- CongressLisa McClain — Ecolab Inc. Common Stock2025-10-30 · Republican · MI · Sale · $1,001 - $15,000
- CongressLisa McClain — Ecolab Inc. Common Stock2025-10-30 · Republican · MI · Purchase · $1,001 - $15,000
- CongressLisa McClain — Ecolab Inc. Common Stock2024-12-11 · Republican · MI · Purchase · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Ecolab Inc (ECL.O) is a diversified specialty chemicals company headquartered in the United States and listed on the NASDAQ exchange. The firm operates within the Basic Materials sector, providing branded formulations and specialty chemical products. As specific operating segment and geographic breakdowns are not provided, the company is described at the industry level as a provider of diversified specialty chemicals.
ECL.AX exhibits a highly liquid capital structure, with a current ratio of 402.04, indicating a strong ability to meet short-term obligations. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative leverage profile. Despite this, the company reported negative operating and free cash flows of -6,292,000 and -3,159,000 AUD respectively, indicating a cash outflow from operations.
Profitability metrics for ECL.AX are modest, with a return on equity (ROE) and return on assets (ROA) of 0.88% each. These figures are below the typical thresholds for high-performing investment management firms, suggesting that the company may not be generating returns at a level that outperforms its cost of capital or industry benchmarks.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if its primary market or client base experiences a downturn.
Looking ahead, ECL.AX is projected to maintain its current revenue trajectory, with no significant growth or decline expected in the next fiscal year. However, the negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund operations, which could impact its long-term growth potential.
Risk factors for ECL.AX include the potential for liquidity constraints due to negative cash flows, although the company currently has no immediate filing-based liquidity or dilution flags. The absence of long-term debt and a low dilution risk score suggest that the company is not under near-term pressure to issue new shares or take on additional debt.
Recent filings and transcripts do not indicate any material events or strategic shifts for ECL.AX. The company's financial statements and disclosures remain consistent with its historical operations, with no significant changes in business strategy or risk profile.
- ECL.AX has a highly liquid balance sheet with a current ratio of 402.04 and no long-term debt.
- The company's ROE and ROA of 0.88% each indicate modest profitability.
- Revenue is concentrated in a single business segment with no geographic diversification.
- Negative operating and free cash flows suggest potential liquidity needs.
- No immediate liquidity or dilution risks are flagged in recent filings.
Bull / Bear case
Generated · model-assistedAnalysts project 23.6% upside to a mean price target of $317.18, reflecting strong consensus buy ratings from 28 analysts.
Revenue grew at a 6.0% compound annual growth rate over the four-year period ending in fiscal year 2026.
Cash conversion ratio of 1.4 is nearly three times the 0.49 median for the diversified specialty chemicals cohort.
Free cash flow declined 10.0% year-over-year to $1.27 billion in fiscal year 2026, signaling weakening cash generation.
Net income decreased 1.7% year-over-year to $2.08 billion in fiscal year 2026, indicating profit pressure despite revenue growth.
Operating income fell 2.3% year-over-year to $2.74 billion in fiscal year 2026, suggesting margin compression risks.
The company faces medium dilution risk, which could negatively impact per-share value for existing equity holders.
Long-term debt increased to $8.24 billion in fiscal year 2026, reversing the previous year's reduction trend.
In focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- CHIEF FINANCIAL OFFICER · Employee Stock Option (Right to Buy) → Common StockDisposed 3 972 @ $117,73exercise · 2026-07-30
- Co-COO - Global Markets · Employee Stock Option (Right to Buy) → Common StockDisposed 10 000 @ $117,73exercise · 2026-06-09
- Director · Non-Employee Stock Option (Right to Buy) → Common StockDisposed 2 000 @ $125,67exercise · 2026-05-22
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option → Common StockAcquired 537 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Director · Non-Employee Director Stock Option (Right to Buy) → Common StockAcquired 732 @ $247,70grant · 2026-05-15
- Co-COO - Global Businesses · Restricted Stock Units → Common StockDisposed 8 396exercise · 2026-05-04
Physical assets
10 tracked| Asset | Type | Commodity | Country | Role |
|---|---|---|---|---|
| NALCO East Kutai power station | Power | Coal | Indonesia | Parent |
| NALCO East Kutai power station | Power | Coal | Indonesia | Parent |
| NALCO East Kutai power station | Power | Coal | Indonesia | Parent |
| NALCO East Kutai power station | Power | Coal | Indonesia | Parent |
| NALCO East Kutai power station | Power | Coal | Indonesia | Parent |
| NALCO East Kutai power station | Power | Power | Indonesia | Parent |
| NALCO East Kutai power station | Power | Power | Indonesia | Parent |
| NALCO East Kutai power station | Power | Power | Indonesia | Parent |
| NALCO East Kutai power station | Power | Power | Indonesia | Parent |
| NALCO East Kutai power station | Power | Power | Indonesia | Parent |
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- ECL.AX Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,32 %$597M
- Institutional Investor · as of 2022-09-300,28 %$0M
- Institutional Investor · as of 2026-03-310,22 %$453M
- Investment Managers · as of 2026-03-310,19 %$269M
- Investment Managers · as of 2026-03-310,16 %$668M
- Investment Managers · as of 2026-03-310,16 %$315M
- Investment Managers · as of 2026-03-310,12 %$2 073M
- Investment Managers · as of 2024-06-300,12 %$5 176M
- Funds · as of 2026-03-310,11 %$692M
- Investment Managers · as of 2026-03-310,10 %$2 993M
- Investment Managers · as of 2026-03-310,10 %$222M
- Investment Managers · as of 2026-03-310,10 %$1 608M
- Investment Managers · as of 2026-03-310,10 %$740M
- Investment Managers · as of 2025-12-310,10 %$6 649M
- Brokerage Firms · as of 2026-03-310,09 %$431M
- Investment Managers · as of 2024-12-310,08 %$290M
- Institutional Investor · as of 2026-03-310,07 %$403M
- Investment Managers · as of 2026-03-310,07 %$534M
- Investment Managers · as of 2026-03-310,07 %$211M
- Investment Managers · as of 2026-03-310,06 %$421M
- Investment Managers · as of 2026-03-310,06 %$339M
- Investment Managers · as of 2026-03-310,06 %$409M
- Investment Managers · as of 2026-03-310,05 %$261M
- Institutional Investor · as of 2026-03-310,05 %$230M
- Investment Managers · as of 2026-03-310,05 %$90M
- Institutional Investor · as of 2026-03-310,04 %$78M
- Brokerage Firms · as of 2026-03-310,03 %$100M
- Investment Managers · as of 2026-03-310,03 %$0M
- Institutional Investor · as of 2026-03-310,03 %$479M
- Investment Managers · as of 2026-03-310,02 %$37M
- Investment Managers · as of 2026-03-310,02 %$74M
- Investment Managers · as of 2026-03-310,02 %$28M
- Investment Managers · as of 2026-03-310,01 %$34M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
Insider activity
- CHIEF FINANCIAL OFFICER · Common StockOther 3 972 @ $117,73$468K · 2026-07-30
- CHIEF FINANCIAL OFFICER · Common StockSold 3 357 @ $276,96$930K · 2026-07-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 46 @ $278,46$13K · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 144 @ $278,46$40K · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- Director · Common StockOther 130 @ $278,46$36K · 2026-06-30
- Director · Common StockOther 130 · 2026-06-30
- EVP - Global Supply Chain · Common StockBought 1 000 @ $263,83$264K · 2026-06-11
- Director · Common StockBought 7 750 @ $258,00$2,0M · 2026-06-10
- Co-COO - Global Markets · Common StockOther 10 000 @ $117,73$1,2M · 2026-06-09
- Co-COO - Global Markets · Common StockSold 10 000 @ $260,89$2,6M · 2026-06-09
- Director · Common StockSold 1 004 @ $264,98$266K · 2026-05-27
- Director · Common StockOther 996 @ $252,27$251K · 2026-05-22
- Director · Common StockOther 2 000 @ $125,67$251K · 2026-05-22
- Director · Common StockBought 1 000 @ $250,65$251K · 2026-05-13
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Current ratio (FY 2025-12-31): 1.08xDerived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -1.2%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 4.9%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -2.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -1.7%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 9.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 10.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 11.6%Derived (calculated)
- Net margin (FY 2025-12-31): 12.9%Derived (calculated)
- Return on equity (FY 2025-12-31): 21.2%Derived (calculated)
- Return on assets (FY 2025-12-31): 8.4%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.52xDerived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 2.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 5.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -48.6%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 0.3%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -2.4%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -1.3%Derived (calculated)
- Operating income (annual): USD 2.74BSEC XBRL filing
- Shares outstanding (annual): 282MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 7SEC XBRL filing
- Current liabilities (annual): USD 5.53BSEC XBRL filing
- Total liabilities (annual): USD 14.89BSEC XBRL filing
- Cash & equivalents (annual): USD 646.2MSEC XBRL filing